A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Biochemistry

• Publication date

  2000-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/J.1432-1327.2000.01055.XPMID 10651813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.

  1999cited by this paper
• A cis proline turn linking two β-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide

  1999cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Standard conformations for the canonical structures of immunoglobulins.

  1997cited by this paper
• Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.

  1997cited by this paper
• Antibody-antigen interactions: contact analysis and binding site topography.

  1996cited by this paper
• CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

  1996cited by this paper
• CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

  1996cited by this paper
• Double-mutant cycles: a powerful tool for analyzing protein structure and function.

  1996cited by this paper
• Contribution of Arginine Residues in the RP135 Peptide Derived from the V3 Loop of gp120 to Its Interaction with the Fv Fragment of the 0.5β HIV-1 Neutralizing Antibody*

  1996cited by this paper
• Structural diversity in a conserved cholera toxin epitope involved in ganglioside binding

  1995cited by this paper
• NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody.

  1995cited by this paper
• Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor.

  1995cited by this paper
• A macromolecular multicomponent peptide vaccine prepared using the glutaraldehyde conjugation method with strong immunogenicity for HIV-1.

  1995cited by this paper
• The principal neutralizing determinant of HIV‐1 located in V3 of gp120 forms a 12‐residue loop by internal hydrophobic interactions

  1995cited by this paper
• Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.

  1995cited by this paper
• Random Copolymers Containing Specific Ratios of Negatively Charged and Aromatic Amino Acids Bind V3 Disulfide Loop and Neutralize Diverse HIV Type 1 Isolates

  1995cited by this paper
• Crystal structure of the principal neutralization site of HIV-1.

  1994cited by this paper
• The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.

  1994cited by this paper
• V3-Mediated Heparin Neutralization of HIV Type 1

  1994cited by this paper
• Antibodies to the HIV-1 V3 loop in serum from infected persons contribute a major proportion of immune effector functions including complement activation, antibody binding, and neutralization.

  1994cited by this paper
• Isotope-Filtered 2D HOHAHA Spectroscopy of a Peptide-Protein Complex Using Heteronuclear Hartmann-Hahn Dephasing

  1994cited by this paper
• Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.

  1993cited by this paper
• Induced peptide conformations in different antibody complexes: molecular modeling of the three-dimensional structure of peptide-antibody complexes using NMR-derived distance restraints.

  1992cited by this paper
• Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.

  1992cited by this paper
• Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV-1IIIB: a two-dimensional NMR study.

  1992cited by this paper
• Isotope-filtered 2D NMR of a protein-peptide complex: study of a skeletal muscle myosin light chain kinase fragment bound to calmodulin

  1992cited by this paper
• Conformation of two non‐immunosuppressive FK506 analogs when bound to FKBP by isotope‐filtered NMR

  1992cited by this paper
• Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

  1991cited by this paper
• Structure, function and properties of antibody binding sites.

  1991cited by this paper
• Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

  1990cited by this paper
• NMR-derived model for a peptide-antibody complex.

  1990cited by this paper
• Calculation of protein extinction coefficients from amino acid sequence data.

  1989cited by this paper
• Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

  1989cited by this paper
• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

  1988cited by this paper
• Characteristics of a Neutralizing Monoclonal Antibody to the HIV Envelope Glycoprotein

  1988cited by this paper
• 5'-3' exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis.

  1988cited by this paper
• Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

  1988cited by this paper
• Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

  1988cited by this paper
• Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

  1988cited by this paper
• MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy

  1985cited by this paper
• An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.

  1975cited by this paper

• Multiplexed Epitope Mapping of HIV-1 Neutralizing Antibodies by Coupling Chemical Labeling of Cysteines to Deep Sequencing.

  2025cites this paper
• Detection of intermolecular NOE interactions in large protein complexes.

  2016cites this paper
• Detection of intermolecular transferred NOEs in large protein complexes using asymmetric deuteration: HIV‐1 gp120 in complex with a CCR5 peptide

  2016cites this paper
• Modelling and predicting the binding mechanics of HIV P1053-0.5β antibody complex

  2011cites this paper
• Structural Model of Ligand-G Protein-coupled Receptor (GPCR) Complex Based on Experimental Double Mutant Cycle Data

  2011cites this paper
• Observation of intermolecular interactions in large protein complexes by 2D-double difference nuclear Overhauser enhancement spectroscopy: application to the 44 kDa interferon-receptor complex.

  2011cites this paper
• Epitope mapping of antibody-antigen complexes by nuclear magnetic resonance spectroscopy.

  2009cites this paper
• NMR evidence of charge‐dependent interaction between various PND V3 and CCR5 N‐terminal peptides

  2009cites this paper
• Structural Basis for Coreceptor Selectivity by The HIV Type 1 V3 Loop

  2007cites this paper
• 3.35 – The Use of NMR Spectroscopy in Carbohydrate–Protein Molecular Interactions

  2007cites this paper
• Middle East and Africa

  2006cites this paper
• HIV-1 gp120 V3 loop for structure-based drug design.

  2005cites this paper
• Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.

  2005cites this paper
• Conformational properties of HIV-1 gp120/V3 immunogenic domains.

  2005cites this paper
• The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding.

  2003cites this paper
• Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.

  2003influential citation
• Synthetic peptide vaccine and antibody therapeutic development: Prevention and treatment of Pseudomonas aeruginosa

  2003cites this paper
• Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.

  2003cites this paper
• Expression, purification, and isotope labeling of the Fv of the human HIV-1 neutralizing antibody 447-52D for NMR studies.

  2003cites this paper
• Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking

  2001cites this paper
• NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.

  2000cites this paper
• Interaction of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: conformation of the bound peptide.

  2000cites this paper